Molecular Mechanisms of Viral and Host Cell Substrate Recognition by Hepatitis C Virus NS3/4A Protease

被引:42
|
作者
Romano, Keith P. [1 ]
Laine, Jennifer M. [1 ]
Deveau, Laura M. [1 ]
Cao, Hong [1 ]
Massi, Francesca [1 ]
Schiffer, Celia A. [1 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA
基金
美国国家卫生研究院;
关键词
CRYSTAL-STRUCTURE; INHIBITOR; REPLICATION; VARIANTS; CLEAVAGE;
D O I
10.1128/JVI.00377-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Hepatitis C NS3/4A protease is a prime therapeutic target that is responsible for cleaving the viral polyprotein at junctions 3-4A, 4A4B, 4B5A, and 5A5B and two host cell adaptor proteins of the innate immune response, TRIF and MAVS. In this study, NS3/4A crystal structures of both host cell cleavage sites were determined and compared to the crystal structures of viral substrates. Two distinct protease conformations were observed and correlated with substrate specificity: (i) 3-4A, 4A4B, 5A5B, and MAVS, which are processed more efficiently by the protease, form extensive electrostatic networks when in complex with the protease, and (ii) TRIF and 4B5A, which contain polyproline motifs in their full-length sequences, do not form electrostatic networks in their crystal complexes. These findings provide mechanistic insights into NS3/4A substrate recognition, which may assist in a more rational approach to inhibitor design in the face of the rapid acquisition of resistance.
引用
收藏
页码:6106 / 6116
页数:11
相关论文
共 50 条
  • [1] Hepatitis C virus NS3/4A protease
    Kwong, AD
    Kim, JL
    Rao, G
    Lipovsek, D
    Raybuck, SA
    ANTIVIRAL RESEARCH, 1998, 40 (1-2) : 1 - 18
  • [2] Hepatitis C virus NS3/4A protease
    Kwong, AD
    CURRENT OPINION IN INFECTIOUS DISEASES, 1997, 10 (06) : 485 - 490
  • [3] Hepatitis C virus NS3/4a protease inhibitors
    McCauley, John A.
    Rudd, Michael T.
    CURRENT OPINION IN PHARMACOLOGY, 2016, 30 : 84 - 92
  • [4] Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease
    Ferreon, JC
    Ferreon, ACM
    Li, K
    Lemon, SM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (21) : 20483 - 20492
  • [5] NS3•4A protease as a target for interfering with hepatitis C virus replication
    Perni, RB
    DRUG NEWS & PERSPECTIVES, 2000, 13 (02) : 69 - 77
  • [6] Resistance outside the substrate envelope: hepatitis C NS3/4A protease inhibitors
    Ozen, Aysegul
    Prachanronarong, Kristina
    Matthew, Ashley N.
    Soumana, Djade I.
    Schiffer, Celia A.
    CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2019, 54 (01) : 11 - 26
  • [7] Bismacrocyclic Inhibitors of Hepatitis C NS3/4a Protease
    McCauley, John A.
    Rudd, Michael T.
    Nguyen, Kevin T.
    McIntyre, Charles J.
    Romano, Joseph J.
    Bush, Kimberly J.
    Varga, Sandor L.
    Ross, Charles W., III
    Carroll, Steven S.
    DiMuzio, Jillian
    Stahlhut, Mark W.
    Olsen, David B.
    Lyle, Terry A.
    Vacca, Joseph P.
    Liverton, Nigel J.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2008, 47 (47) : 9104 - 9107
  • [8] Telaprevir: A Hepatitis C NS3/4A Protease Inhibitor
    Matthews, Samuel James
    Lancaster, Jason W.
    CLINICAL THERAPEUTICS, 2012, 34 (09) : 1857 - 1882
  • [9] The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors
    Romano, Keith P.
    Ali, Akbar
    Aydin, Cihan
    Soumana, Djade
    Oezen, Ayseguel
    Deveau, Laura M.
    Silver, Casey
    Cao, Hong
    Newton, Alicia
    Petropoulos, Christos J.
    Huang, Wei
    Schiffer, Celia A.
    PLOS PATHOGENS, 2012, 8 (07) : 22
  • [10] DDB1 is a cellular substrate of NS3/4A protease and required for hepatitis C virus replication
    Kang, Xi
    Chen, Xi
    He, Ying
    Guo, Deyin
    Guo, Lin
    Zhong, Jin
    Shu, Hong-Bing
    VIROLOGY, 2013, 435 (02) : 385 - 394